Abstract: The present invention relates to certain 2-(2,4,5-substituted-anilino)pyrimidine compounds and pharmaceutically acceptable salts thereof which may be useful in the treatment or prevention of a disease or medical condition mediated through certain mutated forms of epidermal growth factor receptor (for example the L858R activating mutant, the Exon19 deletion activating mutant and the T790M resistance mutant). Such compounds and salts thereof may be useful in the treatment or prevention of a number of different cancers. The invention also relates to pharmaceutical compositions comprising said compounds and salts thereof, especially useful polymorphic forms of these compounds and salts, intermediates useful in the manufacture of said compounds and to methods of treatment of diseases mediated by various different forms of EGFR using said compounds and salts thereof.

Abstract: This invention relates generally to a system and method for providing to patients a medical treatment program, such as a program for physical therapy, and for tracking whether the patient has performed the program correctly. In one aspect, the system and method determines whether the patient has performed the program correctly by comparing feedback from the patient for various parameters associated with an exercise to anticipated values for those parameters. In another aspect, the invention assists medical treatment providers in selecting exercises and tutorials to include in the medical treatment program.

Abstract: This invention relates generally to a method and system for developing or tracking a program for medical treatment. More particularly, the present invention facilitates the development of a treatment program, the retrieval of the program by the patient, the entry of feedback about the program by the patient, and the processing of that feedback.